Sean Grant - Mar 14, 2023 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Stock symbol
VERA
Transactions as of
Mar 14, 2023
Transactions value $
$0
Form type
4
Date filed
4/5/2024, 09:27 PM
Previous filing
Feb 17, 2023
Next filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Gift $0 -14.3K -28.61% $0.00 35.6K Mar 14, 2023 Direct F1
transaction VERA Class A Common Stock Gift $0 +14.3K +1440.02% $0.00 15.3K Mar 14, 2023 By Trust F2
transaction VERA Class A Common Stock Gift $0 -1.62K -7.99% $0.00 18.7K Jul 24, 2023 By Trust F3
transaction VERA Class A Common Stock Gift $0 -636 -3.41% $0.00 18K Dec 20, 2023 By Trust F1
transaction VERA Class A Common Stock Gift $0 +1.62K $0.00 1.62K Jul 24, 2023 As Custodian for UTMA account F4, F5
holding VERA Class A Common Stock 2.82K Mar 14, 2023 By IRA
holding VERA Class A Common Stock 335 Mar 14, 2023 By Roth IRA
holding VERA Class A Common Stock 857 Mar 14, 2023 By Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of shares held directly at the time and after giving effect to the reported gift.
F2 Reflects the number of shares held by the trust at the time and after giving effect to the reported gift.
F3 Reflects the number of shares held by the trust at the time and after giving effect to the reported gift. The number also reflects a purchase reported on a Form 4 filed on June 23, 2023.
F4 The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian.
F5 The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.